While other biologics exist, DiscGenics' cell therapy is distinct due to its standardized manufacturing and progenitor cell source.
: The FDA has granted IDCT Fast Track and Regenerative Medicine Advanced Therapy (RMAT) designations, which may accelerate the approval process. Patient Access and Enrollment diskgen intervertebral
For decades, the gold standard for treating severe degenerative disc disease and chronic back pain was spinal fusion. While effective at stopping motion, fusion came with a significant trade-off: it transferred stress to adjacent vertebral segments, often leading to further degeneration down the line. While other biologics exist, DiscGenics' cell therapy is
I’ll provide the precise report you’re looking for. While other biologics exist
Here’s what I can clarify: